Weisweil, Germany

Roland Schuele

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 2.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Roland Schuele

Introduction

Roland Schuele is a notable inventor based in Weisweil, Germany. He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of gene expression. With a total of six patents to his name, Schuele's work has the potential to impact various therapeutic areas.

Latest Patents

Schuele's latest patents focus on androgen receptor-dependent gene expression control. One of his inventions discloses the use of at least one amine oxidase inhibitor for modulating the activity of the lysine-specific demethylase (LSD1) in mammals. This includes pharmaceutical compositions designed to control androgen receptor-dependent gene expression, comprising an effective dose of the amine oxidase inhibitor. Additionally, his inventions relate to assay systems that allow testing LSD1 inhibitors for their ability to inhibit LSD1 function.

Career Highlights

Throughout his career, Schuele has worked with prestigious institutions, including Universitätsklinikum Freiburg. His research has contributed to advancements in understanding gene expression modulation and its implications for treatment strategies.

Collaborations

Some of Schuele's notable coworkers include Eric Metzger and Erich Metzger. Their collaborative efforts have likely enhanced the research and development of innovative solutions in their field.

Conclusion

Roland Schuele's contributions to the field of gene expression modulation through his patents highlight his innovative spirit and dedication to advancing pharmaceutical sciences. His work continues to pave the way for future research and therapeutic developments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…